"I am thrilled to report the company's strongest first half period as we continue to execute on our growth strategy and remain focused on increasing formulary coverage for our high value medications," commented .
http://www.hispanicbusiness.com/2013/8/20/targeted_medical_pharma_posts_2013_second.htm
http://www.hispanicbusiness.com/2013/8/20/targeted_medical_pharma_posts_2013_second.htm
No comments:
Post a Comment